Skip to content

Lucid Diagnostics LUCD Other Income (Expense)

Other Income (Expense) at other companies

Castle Biosciences logo
Castle BiosciencesCSTL
-$439K
Guardant Health logo
Guardant HealthGH
-$157K-102%
Biodesix, Inc. logo
Biodesix, Inc.BDSX
-$1.59M+19.0%
Insight Molecular Diagnostics Inc. Common Stock logo
Insight Molecular Diagnostics Inc. Common StockIMDX
$123K-3.9%
Fulgent Genetics, Inc. logo
Fulgent Genetics, Inc.FLGT
$8.64M+7.1%
Personalis, Inc. logo
Personalis, Inc.PSNL
$20K+143%

Other financials

Income statement

See full
Revenue$1.3M+51.7%
Gross profit-$369.0K+49.0%
Operating income-$12.1M+3.0%
Net income-$13.9M+48.3%
EPS (diluted)-$0.10+60.0%

Balance sheet

See full
Cash & equivalents$27.9M+10.6%
Total debt$1.6M-35.1%
Total equity$4.0M+174%
Total assets$34.1M+3.9%

Cash flow

See full
Operating cash flow-$12.1M+2.9%
CapEx$215.0K+131%
Free cash flow-$12.3M+1.9%

Valuation

See full
Market cap$204.13M+58.5%
Enterprise value$177.85M+78.0%
P/S39.8×+10.2×

Profitability

See full
Gross margin-66.8%
Operating margin-959.6%-133pp
Net margin-876.7%-254pp
FCF margin-1,099.6%

Returns & leverage

See full
Return on equity-710.6%
Debt / equity0.4×
Current ratio1.1×+0.3×

Where this comes from

Reported directly by Lucid Diagnostics in its filing.

Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.

The official record: Lucid Diagnostics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lucid Diagnostics's other income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Lucid Diagnostics's other income (expense)?
Lucid Diagnostics (LUCD) reported other income (expense) of -$1.8M in Q1 2026.
How has Lucid Diagnostics's other income (expense) changed year-over-year?
Lucid Diagnostics's other income (expense) increased by 87.6% year-over-year, from -$14.42M to -$1.8M.
What is the long-term trend for Lucid Diagnostics's other income (expense)?
Over 3 years (2021 to 2025), Lucid Diagnostics's other income (expense) has grown at a 133.3% compound annual growth rate (CAGR), from -$659K to -$8.37M.
What does other income (expense) mean?
Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.